SEC
SlamSEC
SearchBrowseEarnings

Lexaria Bioscience Corp.

Nasdaq:LEXX
Pharmaceutical Preparations·KELOWNA, A1
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(1001 total)

TypeDateAccessionPeriodSize
8-K
Feb 6, 2026
0001640334-26-000230FORM 8-K
Feb 4, 2026
135.7 KB
8-K
Jan 28, 2026
0001640334-26-000162FORM 8-K
Jan 27, 2026
151.6 KB
S-8
Jan 28, 2026
0001640334-26-000159FORM S-8
—
348.7 KB
EFFECT
Jan 14, 2026
9999999995-26-000171
—
1.9 KB
424B3
Jan 14, 2026
0001640334-26-000089424B3
—
185.0 KB
25-NSE
Jan 14, 2026
0001354457-26-000039
—
3.1 KB
10-Q
Jan 13, 2026
0001640334-26-000080FORM 10-Q
Nov 30, 2025
4.5 MB
S-3
Dec 29, 2025
0001640334-25-002382FORM S-1
—
466.8 KB
D
Dec 19, 2025
0001348362-25-000018
—
12.7 KB
8-K
Dec 16, 2025
0001640334-25-002348FORM 8-K
Dec 14, 2025
757.4 KB
424B5
Dec 16, 2025
0001640334-25-002331424B5
—
341.6 KB
DEF 14A
Dec 10, 2025
0001640334-25-002275FORM DEF 14A
Jan 27, 2026
1.3 MB
EFFECT
Dec 9, 2025
9999999995-25-003607
—
1.9 KB
424B3
Dec 9, 2025
0001640334-25-002271424B3
—
188.5 KB
EFFECT
Dec 8, 2025
9999999995-25-003563
—
1.9 KB
POS AM
Dec 5, 2025
0001640334-25-002260POS AM
—
276.2 KB
S-1/A
Dec 5, 2025
0001640334-25-002256FORM S-1/A
—
287.7 KB
10-K
Nov 28, 2025
0001640334-25-002225FORM 10-Q
Aug 31, 2025
6.1 MB
S-1
Oct 14, 2025
0001640334-25-001839FORM S-1
—
9.1 MB
D
Oct 1, 2025
0001348362-25-000017
—
12.6 KB
8-K
Sep 29, 2025
0001640334-25-001742FORM 8-K
Sep 26, 2025
772.3 KB
424B5
Sep 29, 2025
0001640334-25-001727424B5
—
356.2 KB
8-K
Sep 25, 2025
0001640334-25-001717FORM 8-K
Sep 19, 2025
152.9 KB
4
Jul 30, 2025
0001348362-25-000016PRIMARY DOCUMENT
Jul 29, 2025
15.7 KB
4
Jul 30, 2025
0001348362-25-000015PRIMARY DOCUMENT
Jul 29, 2025
15.7 KB
25 filings shown
CEO
Christopher Richard